portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


 Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw Annual Global Investment Conference
 
CreateTime:2011-09-08     Source:marketwatch Editor:lile
Text Size:       
 

XI'AN, CHINA, Sep 06, 2011  -- Skystar Bio-Pharmaceutical Company (SKBI.NSDQ) ,a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Waldorf-Astoria in New York City on Tuesday, September 13, 2011 at 10:00 am Eastern time.

The conference will include a series of one-on-one meetings with institutional investors. Investors interested in scheduling a meeting with the management team can facilitate a request by contacting the Company at skystar@grayling.com or alternatively contact their Rodman & Renshaw representative directly.

Offsite management meetings with institutional investors in New York City with Skystar's management can be arranged, please contact Christopher Chu for more details.

A slide archive of the presentation will be available under the "Events and Presentations" page on the "Investor Relations" section of the Company's website at http://www.ir-site.com/skystar/events.asp .

To request a one-on-one meeting or to be added to Skystar's email list, please contact Christopher Chu at skystar@grayling.com or call 646-284-9426.

To be added to the Company's email distribution for future news releases, please send your request to skystar@grayling.com.

About Skystar Bio-Pharmaceutical Company Skystar is a China-based developer and distributor of veterinary healthcare and medical care products. Skystar has four product lines (veterinary medicines, micro-organisms, vaccines and feed additives) and 263 products. Skystar has formed strategic sales distribution networks covering 29 provinces throughout China. For additional information, please visit http://www.skystarbio-pharmaceutical.com .
 


Related Reports
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
Global and China Monoclonal Antibody Industry Report, 2019-2025
China Contract Research Organization (CRO) Industry Report, 20...
2005-2010 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1